Extract from our M&A Insights

Read more about our Nordic and DACH M&A Insights services including the M&A Portal and Private Equity Portfolio Tracker.
Impilo invests in Swedish HIV diagnostics company Cavidi
February 21, 2018

Impilo has invested in a 29% stake in Cavidi AB, an Uppsala-based diagnostics company focused on HIV Viral Load monitoring. Cavidi has developed a new fully automated viral load diagnostic platform. This platform, Ziva™, aims to meet the need for cost-effective monitoring in high-disease burden countries.

ⓘ This story was originally featured in our daily Nordic M&A Newsletter - we publish some of the newsletter content with delay through our M&A Newsletter Library. If you would like more insights on this deal or industry then send us an email at requests@nordicknowledgepartners.com